Next-generation drug delivery technology

Delgen Biosciences is developing an advanced drug delivery technology based on a proprietary polymer design and synthesis platform. These novel polymers possess many coveted features at the molecular level, making them an ideal vehicle for delivering protein drugs with precision, duration, and controlled release. The technology is capable to become an alternative modality that will transform current standard-of-care retinal disease treatments and the broader pharmaceutical space.